ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,326, issued on Dec. 16, was assigned to NOVALIQ GMBH (Heidelberg, Germany).
"Ophthalmic composition for treatment of dry eye disease" was invented by Markus Beier (Weinheim, Germany), Jorg Haisser (Siegelsbach, Germany), Alice Meides (Heidelberg, Germany), Sonja Krosser (Heidelberg, Germany), Hartmut Voss (Schriesheim, Germany), Frank Loscher (Schriesheim, Germany) and Bernhard Gunther (Dossenheim, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides pharmaceutical compositions comprising about 0.05 to 0.1% (w/v) cyclosporine dissolved in 1-perfluorobutyl-pentane for use in the topical treatment of dry eye disease and provid...